跳到主要內容

Broadrick Dale 的 Form 4 申報

BioRestorative Therapies, Inc.(BRTX),2022/3/29 申報

申報編號
0001567619-22-007664
申報時間
2022/3/29
交易日
2022/3/1-3/21
申報延遲
28 天遲報
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 8 筆非衍生性交易。公開市場買進合計 $79.4 萬。交易後 28 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Broadrick DaleCIK 0001677513持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/3/1Common StockP買進取得+2,270$5.55+$12,598.5201,984間接
2022/3/2Common StockP買進取得+47,840$5.61F2+$268,382.4249,824間接
2022/3/3Common StockP買進取得+47,648$5.47F3+$260,634.56297,472間接
2022/3/4Common StockP買進取得+3,800$5.51+$20,938301,272間接
2022/3/7Common StockP買進取得+24,392$4.43F4+$108,056.56175,853直接
2022/3/8Common StockP買進取得+8,125$4.00+$32,500183,978直接
2022/3/9Common StockP買進取得+11,875$4.00+$47,500195,853直接
2022/3/21Common StockP買進取得+10,000$4.35+$43,500205,853直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $5.56 to $5.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F3

This transaction was executed in multiple trades at prices ranging from $5.39 to $5.60 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F4

This transaction was executed in multiple trades at prices ranging from $3.97 to $4.53 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)